Michael Zdanowski is Chief Technology Officer of Talaris Therapeutics, Inc.. Currently has a direct ownership of 121,470 shares of TALS, which is worth approximately $330,398. The most recent transaction as insider was on Sep 10, 2022, when has been sold 120,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K
0% 3M change
0% 12M change
Total Value Held $330,398

Michael Zdanowski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 10 2022
BUY
Grant, award, or other acquisition
-
120,000 Added 49.7%
121,470 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$19,110 $13.0 p/Share
1,470 Added 50.0%
1,470 Common Stock
MZ

Michael Zdanowski

Chief Technology Officer
Wellesley, MA

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Track Activities on TALS